Wednesday, September 7, 2016 - Thursday, September 7, 2017 12:00 AM
At the conclusion of this activity, participants should be able to:
- Understand indications and guidelines for use of Proton Pump Inhibitors (PPI’s);
- Use published information about risks of PPI use to inform clinical decision-making; and
- Discuss responsible drug prescribing.
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits
™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.